Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,194,621
+$880,906 QoQ
Shares Held
24,617
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1,185
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 28%
Shared 72%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NICHOLS & PRATT ADVISERS LLP /MA holds $207,768,859 across 8 Drug Manufacturers - General names. ABBV ranks #4 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
460,889 | $117,051,979 | |
| 2 | MRK |
Merck & Co., Inc.
|
442,799 | $56,899,671 | |
| 3 | NVO |
Novo Nordisk A S
|
477,675 | $22,899,738 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
24,617 | $6,194,621 | |
| 5 | NVS |
Novartis AG
|
17,297 | $2,710,784 | |
| 6 | AMGN |
Amgen Inc
|
2,897 | $1,049,060 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,525 | $548,830 | |
| 8 | PFE |
Pfizer Inc
|
17,200 | $414,176 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,194,621 | 24,617 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,313,715 | 24,432 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $5,628,165 | 24,632 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $5,672,498 | 24,499 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,596,692 | 24,764 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $5,314,264 | 25,364 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $4,655,562 | 26,199 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $5,252,967 | 26,600 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $4,671,346 | 27,235 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $5,087,874 | 27,940 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $4,339,469 | 28,002 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $4,169,505 | 27,972 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,715,179 | 27,575 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $4,358,769 | 27,350 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $4,539,624 | 28,090 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $3,680,037 | 27,420 | Shares | Other | 2022-11-01 | |
| 2022-06-30 | $4,073,289 | 26,595 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $4,299,157 | 26,520 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,567,113 | 26,345 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,728,571 | 25,295 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,623,384 | 23,290 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,366,229 | 21,865 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,263,298 | 11,790 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $529,919 | 6,050 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $525,263 | 5,350 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $407,616 | 5,350 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||